| Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation CC Chang, I Khan, KL Tsai, H Li, LW Yang, RH Chou, C Yu Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1864 (11), 1558-1569, 2016 | 34 | 2016 |
| Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain MI Khan, D Dowarha, R Katte, RH Chou, A Filipek, C Yu PLoS One 14 (5), e0216427, 2019 | 30 | 2019 |
| S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain MI Khan, YK Su, J Zou, LW Yang, RH Chou, C Yu PLoS One 13 (2), e0190545, 2018 | 19 | 2018 |
| S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain MI Khan, T Yuan, RH Chou, C Yu PLoS One 14 (2), e0212299, 2019 | 7 | 2019 |
| Suramin derivatives play an important role in blocking the interaction between FGF1 and FGFRD2 to inhibit cell proliferation N Parveen, YL Lin, MI Khan, RH Chou, CM Sun, C Yu European Journal of Medicinal Chemistry 206, 112656, 2020 | 6 | 2020 |
| Long-range proton transport in films from a reflectin-derived polypeptide C Xu, N Kandel, X Qiao, MI Khan, P Pratakshya, NE Tolouei, B Chen, ... ACS Applied Materials & Interfaces 13 (18), 20938-20946, 2021 | 4 | 2021 |
| Modification of physicochemical and micromeritic properties of active pharmaceutical ingredient by crystallization technique SR Giram, P. S., Khan Md Imran and More Int. J. Curr. Res 7, 13405-13409, 2015 | | 2015 |
